16:54 EDT Lenz Therapeutics (LENZ) files $500M mixed securities shelf
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LENZ:
- Lenz Therapeutics’ Earnings Call Highlights Positive Outlook
- Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch
- Lenz Therapeutics price target raised to $38 from $37 at BofA
- LENZ Therapeutics: Innovative Presbyopia Treatment and Strategic Growth Reinforce Buy Rating
- Promising Outlook for LENZ Therapeutics: Buy Rating Backed by Strategic Marketing and Anticipated FDA Approval